EPILEPSY THERAPIES & DIAGNOSTICS DEVELOPMENT XIX

(ETDD - formally AEDD)

June 9th – June 11th , 2027
JW Marriott Miami Turnberry Resort
19999 West Country Club Drive, Aventura Florida, 33180

Welcome to the website for the 19th conference on Epilepsy Therapies & Diagnostic Development (formally the Antiepileptic Drug & Device Symposium), held every two years and sponsored by the Epilepsy Study Consortium, Inc. in collaboration with the University of Pennsylvania and the Epilepsy Foundation.

If you have any questions about the conference, please contact Tracy DeVito devito@epilepsycosortium.org or Bree DiVentura diventura@epilepsystudyconsortium.org at the Epilepsy Study Consortium.

Program

This is the nineteenth conference focusing on issues related to Epilepsy Therapies & Diagnostic Developments (ETDD) from preclinical discoveries through clinical evaluations. We are fortunate to have a robust epilepsy drug and device pipeline, fueled by excellent science and novel ideas. We are entering an exciting era where therapies targeted at disease modification , rather than just anti-seizure treatment are emerging, and there is a focus on personalized treatments. There are also many treatments in the pipeline for orphan diseases. There is a burgeoning pipeline of wearable and implantable diagnostic devices. New therapeutic devices are also under development. New innovations in therapy and diagnostics may face roadblocks such as complex regulatory requirements, increased payer expectations, and issues in data quality, but progress has been made. At each ETDD conference, we re-evaluate strategies to ensure continued advancement. There is always the opportunity to learn from the past as we move into the future. This symposium will bring together representatives from academia, industry, and the NIH, to review what has been learned and to discuss strategies to enhance epilepsy therapy and diagnostics development.

Click HERE to download the previous (2025 conference) agenda.

Registration - Conference & Hotel

conference registration & Payment

Registration for the ETDD 2027 meeting will open in February 2026.

Meeting dates: June 9 - June 11, 2027.

Register online HERE.

Printable registration form HERE.

RATES

General In-Person Registration: $
General Virtual Registration: $
Coordinator/Nurse In-Person Registration: $
Coordinator/Nurse Virtual Registration: $
On Site Registration: $

Hotel reservations

We are planning an in-person meeting in a venue we know well:

JW Marriott Miami Turnberry Resort
19999 West Country Club Drive,
Aventura Florida, 33180

The Hotel Booking Link will be stated below when hotel reservations open.

The last date for the conference room rate will be stated below when resevations open.

Meeting Purpose

In an era where we have BROUGHT numerous new antiepileptic drugs to the marketplace, we need to be mindful of the unmet needs….

For more than three decades a group of individuals have been meeting on a biennial basis to discuss ways in which the process of bringing innovative therapies and devices to patients can be expedited. Participants include individuals from academia, from interested government agencies, as well as representatives from the pharmaceutical and device industries. The purpose of these meetings has been the exchange of ideas, discussion of roadblocks to therapeutic and diagnostic development, dialogue about regulatory strategies, and sharing of successful approaches. Over the years, discussions at this symposium have led to implementation of new trial designs, as well as new important analyses of trials that have already been performed. In addition, new regulatory pathways have been identified, particularly as related to approval of new antiepileptic drugs for monotherapy use. In addition, each meeting presents a pipeline of drugs and devices currently in development, and includes a Shark Tank competition, where novel innovations to improve the lives of people with epilepsy are presented.

Objectives

During the course of the meeting, participants will:

Obtain an understanding of the processes by which new drugs are discovered, including discussion of new animal models and molecular targets.
Discuss new translational models in the epilepsy space.
Discuss new regulatory pathways for epilepsy approval, including orphan indications.
Discuss new ways to assess seizure frequency in trials, including electronic seizure diaries, wearable devices, and continuous EEG.

Discuss new objectives and legislation that have an impact on ASM development.
Discuss novel outcome measures, including those for co-morbidities.
Summarize discussions from previous Research Roundtables for Epilepsy regarding measurement of seizure impact beyond seizure counts.
Outline the drugs and devices in preclinical and clinical development for epilepsy.

Travel Grants

new in 2025 and still available in 2027! Travel Grants

Application due date will appear here.

The Epilepsy Foundation, the Epilepsy Study Consortium, Inc., and the Pediatric Epilepsy Research Foundation® have pooled their funds to provide travel grants to the conference for Epilepsy Fellow/Junior Faculty and Pediatric Epilepsy Fellows. Please see guidelines to apply.